Please wait while we open this resource.
K
Guidelines & protocols
NORTH-EAST GUIDELINE FOR USE OF SODIUM GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2I)
Endocrinology
PDF5 pages440 KB
The document provides comprehensive recommendations for the use of SGLT2 inhibitors, detailing their indications, dosing, and safety information. It emphasizes the importance of clinical judgment and the need for up-to-date knowledge on medication licenses, as these can change rapidly. The guideline also addresses the management of associated risks, such as lower limb amputation, and offers recommendations for patient monitoring and education.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
Uganda Diabetes Management Guidelines – Summarised (2026)
Same clinical topic · Endocrinology
Kiruddu DKA guidelines
Same clinical topic · Endocrinology
Pharmacotherapy for Obesity Management: 2025 Guidelines
Same clinical topic · Endocrinology
Management of DKA
Same clinical topic · Endocrinology
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGY CONSENSUS STATEMENT ALGORITHM FOR MANAGEMENT OF ADULTS WITH TYPE 2 DIABETES — 2026 UPDATE
Same clinical topic · Endocrinology
GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CONGENITAL HYPOTHYROIDISM
Same clinical topic · Endocrinology
2026 ETA GUIDELINE ON INTERFERENCE IN IMMUNOASSAY MEASUREMENTS USED IN ASSESSMENT OF THYROID FUNCTION
Same clinical topic · Endocrinology
CANADIAN ADULT OBESITY CLINICAL PRACTICE GUIDELINE: PHARMACOTHERAPY FOR OBESITY MANAGEMENT IN ADULTS
Same clinical topic · Endocrinology
Nutritional Management of Diabetes SOP (2)
Same clinical topic · Endocrinology